chr7-259915-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1
The NM_020223.4(FAM20C):āc.1690A>Gā(p.Asn564Asp) variant causes a missense change. The variant allele was found at a frequency of 0.458 in 1,534,002 control chromosomes in the GnomAD database, including 164,582 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.52 ( 21013 hom., cov: 35)
Exomes š: 0.45 ( 143569 hom. )
Consequence
FAM20C
NM_020223.4 missense
NM_020223.4 missense
Scores
17
Clinical Significance
Conservation
PhyloP100: 4.01
Genes affected
FAM20C (HGNC:22140): (FAM20C golgi associated secretory pathway kinase) This gene encodes a member of the family of secreted protein kinases. The encoded protein binds calcium and phosphorylates proteins involved in bone mineralization. Mutations in this gene are associated with the autosomal recessive disorder Raine syndrome. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
PM1
In a region_of_interest Kinase domain (size 211) in uniprot entity FA20C_HUMAN there are 8 pathogenic changes around while only 1 benign (89%) in NM_020223.4
BP4
Computational evidence support a benign effect (MetaRNN=6.8630966E-6).
BP6
Variant 7-259915-A-G is Benign according to our data. Variant chr7-259915-A-G is described in ClinVar as [Benign]. Clinvar id is 193731.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-259915-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.66 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM20C | NM_020223.4 | c.1690A>G | p.Asn564Asp | missense_variant | 10/10 | ENST00000313766.6 | NP_064608.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM20C | ENST00000313766.6 | c.1690A>G | p.Asn564Asp | missense_variant | 10/10 | 1 | NM_020223.4 | ENSP00000322323 | P1 | |
FAM20C | ENST00000515795.1 | n.1347A>G | non_coding_transcript_exon_variant | 7/7 | 1 |
Frequencies
GnomAD3 genomes AF: 0.515 AC: 78372AN: 152054Hom.: 20974 Cov.: 35
GnomAD3 genomes
AF:
AC:
78372
AN:
152054
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.436 AC: 61169AN: 140220Hom.: 14317 AF XY: 0.437 AC XY: 32948AN XY: 75324
GnomAD3 exomes
AF:
AC:
61169
AN:
140220
Hom.:
AF XY:
AC XY:
32948
AN XY:
75324
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.452 AC: 624259AN: 1381830Hom.: 143569 Cov.: 66 AF XY: 0.451 AC XY: 307215AN XY: 681428
GnomAD4 exome
AF:
AC:
624259
AN:
1381830
Hom.:
Cov.:
66
AF XY:
AC XY:
307215
AN XY:
681428
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.516 AC: 78462AN: 152172Hom.: 21013 Cov.: 35 AF XY: 0.516 AC XY: 38407AN XY: 74382
GnomAD4 genome
AF:
AC:
78462
AN:
152172
Hom.:
Cov.:
35
AF XY:
AC XY:
38407
AN XY:
74382
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1626
ALSPAC
AF:
AC:
1658
ESP6500AA
AF:
AC:
905
ESP6500EA
AF:
AC:
1409
ExAC
AF:
AC:
8679
Asia WGS
AF:
AC:
1729
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 21, 2016 | p.Asn564Asp in exon 10 of FAM20C: This variant is not expected to have clinical significance because it has been identified in 72.54% (959/1322) of African chro mosomes by the 1000 Genomes Project (Phase 3; dbSNP rs36139924). - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 20, 2014 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2018 | - - |
Lethal osteosclerotic bone dysplasia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
P
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at